NIDA Notes keeps you up to date on research advances in the causes, consequences, prevention, and treatment of drug abuse and addiction and HIV/AIDS.
Learn more about NIDA Notes
Describes the role of the Division of Clinical Neuroscience and Behavioral Research in NIDA’s drug abuse and addiction research plan.
Presents highlights of a study indicating that exposure to morphine during adolescence may increase sensitivity to the drug during adulthood.
Reports on the work of addiction researchers who are learning how acute and chronic cocaine exposure regulates certain genes, based on knowledge from developmental and cancer biology.
Announces updates to research reports on MDMA/ecstasy and steroids and a new report on HIV/AIDS that provide the latest available information on drugs and drug-related topics.
Reports on data that reviewing the benefits of addiction treatment among abstinent men as compared with those who continued to abuse cocaine.
Summarizes animal studies indicating that an antipsychotic drug, trifluoperazine, prevents morphine tolerance in mice.
Presents results of a pilot study to investigate the safety and efficacy of a new long-lasting injectable formulation of naltrexone to treat of heroin addiction in an outpatient setting.
Reports on the work of scientists who have linked impulsiveness and risk-taking among adolescents to immaturity of the brain region called the orbitofrontal cortex.
Summarizes a study on the use of incentives to encourage abstinence among methadone maintenance patients in outpatient programs.
The Rise and Fall of the Cocaine High
Researchers Speak: Dr. Kevin M. Gray